COVID-19 pandemic: transmission of SARS-CoV-2 in animals, a risk for human beings

Articles in the same Issue

1. Frontmatter
2. Letter to the Editor
3. COVID-19 pandemic: transmission of SARS-CoV-2 in animals, a risk for human beings
4. Original Articles
5. Anti Mullerian hormone as a diagnostic tool for polycystic ovary syndrome in women of reproductive age with morbid obesity
6. Potential tumor marker for hepatocellular carcinoma identification: PI3K and pro-inflammatory cytokines (TGF-β, IL-1, and IL-6)
7. The investigation of the frequency of the alpha-1-antitrypsin phenotype in patients with liver cirrhosis
8. Anti-oxidant effect of metformin through AMPK/SIRT1/PGC-1α/SIRT3– independent GPx1 expression in the heart of mice with endometriosis
9. Hypoxia-inducible factor-1α and ischemia-modified albumin levels in intensive care COVID-19 Patients
10. Association between TP53 Arg72Pro variant and recurrent pregnancy loss in the Greek population
11. Selective estrogen receptor α and β antagonist aggravate cardiovascular dysfunction in type 2 diabetic ovariectomized female rats
12. Adrenocorticotropic hormone (ACTH) level and adrenal deficiency in patients with mucocutaneous pemphigus
13. The effect of resistance training on serum levels of sex hormones and sperm quality in male rats under X-ray radiation
14. The effect of high-intensity interval training on serum and adipose tissues vaspin levels in rats fed a high-fat high-sucrose diet
15. Anti-migratory effect of curcumin on A-549 lung cancer cells via epigenetic reprogramming of RECK/ matrix metalloproteinase axis
16. Efficacy of rectal progesterone on maternal and neonatal outcomes in pregnant women with Preterm Premature Rupture of membranes: a triple-blind randomised clinical trial
17. Case Report
18. Ovarian tissue cryopreservation in Malaysia: a case series
19. Review Articles
20. An overview of prognostic value of neurologic and cardiac biomarkers in patients with COVID-19 sequelae
21. Potential role of melatonin in prevention and treatment of lung cancer
22. Esketamine–A quick-acting novel antidepressant without the disadvantages of ketamine